Review Claim by Claim

 Long Answer Copied

Core Mechanism Claimed

Zhang et al. (Virus Research, 2014) report that EV71 infection of RD cells activates PI3K/Akt within 15–60 minutes post infection, and that this early survival signal limits JNK-driven, Bax-dependent mitochondrial apoptosis by Akt-mediated phosphorylation of ASK1 at Ser83. JNK activation persists from ~0.5 to 8 hpi; the JNK inhibitor SP600125 blocks Bax mitochondrial translocation, cytochrome c release, and apoptosis, while wortmannin (1 μM) or Akt siRNA enhance all three readouts. ASK1 knockdown suppresses JNK phosphorylation, placing ASK1 upstream of JNK in this axis. Zhang et al. 2014 EV71 PI3K/Akt–JNK apoptosis paper

Note: kinetic curves are schematic reconstructions of the qualitative Western blot time courses; exact densitometry values were not provided numerically in the text.

Novelty and Context

The central novelty is the explicit ASK1 bridge between Akt and JNK during EV71 infection, directly paralleling the poliovirus model where early PI3K/Akt activation limits JNK-mediated cell death via ASK1 Ser83 phosphorylation. Early phosphatidylinositol 3-kinase/Akt pathway activation limits poliovirus-induced JNK-mediated cell death [2008] The EV71 paper is thus an extension of an established picornavirus paradigm to a new virus/cell type rather than a fundamentally new concept, which the authors themselves acknowledge.

Critical Appraisal and Blind Spots

• Single-cell-type, in-vitro only: All findings derive from RD cells with the BrCr-Tr strain at MOI 1; extrapolation to neurons or in-vivo infection is untested. Methods and sample-size details of the EV71 study
• Pharmacological reliance: Conclusions rest heavily on wortmannin and SP600125, both with documented off-target effects; genetic rescue experiments (e.g., ASK1-S83A mutants) are absent, so direct causality Akt→ASK1 Ser83→JNK remains inferential rather than demonstrated.
• No quantified effect sizes: Apoptosis is reported as flow-cytometric percentages only in figure form; no fold-change values or confidence intervals appear in the text, limiting meta-analytic utility.
• Missing controls: No direct ASK1 kinase assay or phospho-mimetic/non-phosphorylatable ASK1 mutant was used to confirm that Ser83 phosphorylation functionally inactivates ASK1 during infection.
• Falsification path: The model would fail if ASK1-S83A expression rescues JNK activation under Akt-active conditions, or if Akt knockdown fails to increase apoptosis in neurons or other permissive cell types.

Explore Further

 BGPT Paper Review

Study Novelty

First demonstration of PI3K/Akt–ASK1–JNK crosstalk during EV71 infection, but the paradigm is directly transferred from poliovirus (Autret et al. 2008), reducing conceptual novelty to an extension to a new virus/cell system.

Scientific Quality

Methodologically sound (multiple orthogonal readouts: Western blot, IP, fractionation, flow cytometry, siRNA) but weakened by reliance on inhibitors with off-target effects, absence of ASK1 phospho-mutant rescue experiments, qualitative-only densitometry, and no in-vivo validation.

Study Generality

Findings are confined to one cell line (RD) and one viral strain; while the mechanism likely generalizes across picornaviruses, no cross-cell-type or in-vivo evidence supports broader applicability.

Study Usefulness

Provides a clear mechanistic model relevant to EV71 neuropathogenesis and identifies ASK1/JNK as potential host-directed intervention points, though translational impact is limited by the in-vitro scope.

Study Reproducibility

Methods are described in adequate detail (antibody catalog numbers, siRNA sequences, inhibitor concentrations, MOI), but raw densitometry values, full statistical treatment, and data availability statements are missing, hindering exact replication.

Explanatory Depth

The paper builds a coherent multi-step causal chain (PI3K→Akt→ASK1 Ser83→JNK→Bax→cytochrome c→apoptosis) with inhibitor and knockdown logic, but stops short of direct kinase assays or mutational proof at the ASK1 node.